Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LLL 3348

Drug Profile

LLL 3348

Alternative Names: Desoris; Herbal anti-psoriasis compound LLL-3348 (Desoris) - Lupin Ltd; LL 3348; LLL-3348

Latest Information Update: 18 Jun 2015

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Lupin
  • Class Antipsoriatics
  • Mechanism of Action Cell modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • No development reported Plaque psoriasis

Most Recent Events

  • 18 Jun 2015 No recent reports on development identified - Phase-II/III for Plaque psoriasis in India (PO)
  • 11 Dec 2013 Lupin completes a phase II/III trial in Plaque psoriasis in India
  • 05 Apr 2011 Lupin completes enrolment in its phase IIb/III trial for Plaque psoriasis in India
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top